Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
Chimin Health Management Co., Ltd., formerly known as Zhejiang Chimin Pharmaceutical Co.,Ltd., is a Chinese enterprise specializing in the research, production, and distribution of pharmaceuticals for human use and medical apparatus. Its product offerings include diverse medical packaging options, such as non-PVC soft bags with various valve configurations (e.g., double-tube double valves, single valves, single-tube double valves), plastic bottles, and other specialized containers. The company also supplies an extensive array of injection and infusion devices, encompassing safety syringes, safety injection needles, sterile syringes, irrigators, dispensers, insulin syringes, as well as standard and precision filter infusion sets. Beyond these, Chimin Health Management provides in-vitro diagnostic products, hemodialysis supplies, and delivers medical services. The firm was established in 1996 and maintains its principal operations in Huangyan, China.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers.